{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:21:33Z","timestamp":1769826093869,"version":"3.49.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.japh.2024.01.003","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:37:14Z","timestamp":1704947834000},"page":"588-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using insulin pump for glycemic control in patients with severe insulin resistance"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2955-6541","authenticated-orcid":false,"given":"Maria","family":"Procaccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9341-2158","authenticated-orcid":false,"given":"Anthony Garrett","family":"Allegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5258-3664","authenticated-orcid":false,"given":"Dana","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3961-853X","authenticated-orcid":false,"given":"Evan","family":"Sisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2024.01.003_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2822","article-title":"The role of insulin pump therapy for type 2 diabetes mellitus","volume":"33","author":"Landau","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"issue":"7","key":"10.1016\/j.japh.2024.01.003_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/dia.2013.0363","article-title":"OpT2mise: a randomized controlled trial to compare insulin pump therapy with multiple daily injections in the treatment of type 2 diabetes-research design and methods","volume":"16","author":"Aronson","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"10.1016\/j.japh.2024.01.003_bib3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1089\/dia.2010.0110","article-title":"Efficacy of continuous subcutaneous insulin infusion in type 2 diabetes mellitus: a survey on a cohort of 102 patients with prolonged follow-up","volume":"12","author":"Reznik","year":"2010","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.japh.2024.01.003_bib4","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-2007-970423","article-title":"Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure","volume":"39","author":"Berthe","year":"2007","journal-title":"Horm Metab Res"},{"issue":"3","key":"10.1016\/j.japh.2024.01.003_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101300","article-title":"The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: a cohort survey","volume":"48","author":"Deberles","year":"2022","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.japh.2024.01.003_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.diabres.2018.12.007","article-title":"Concentrated insulins in current clinical practice","volume":"148","author":"Schloot","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"10.1016\/j.japh.2024.01.003_bib8","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.2337\/dc23-S009","article-title":"Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.japh.2024.01.003_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/dom.13947","article-title":"Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: the VIVID study","volume":"22","author":"Grunberger","year":"2020","journal-title":"Diabetes Obes Metab"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:53:17Z","timestamp":1761544397000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1544319124000037"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.01.003","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using insulin pump for glycemic control in patients with severe insulin resistance","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}